← Back to Search

Robotic-Assisted Rehabilitation for Stroke

N/A
Recruiting
Research Sponsored by University of Delaware
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during intervention
Awards & highlights
No Placebo-Only Group

Summary

This trial is exploring ways to help people recover from stroke, which is a leading cause of death and disability in the US. It hopes to improve walking speed and quality of life for those affected.

Who is the study for?
This trial is for adults aged 18-80 who are in good health or have had a single stroke over 6 months ago. Healthy participants must pass a fitness questionnaire, while stroke survivors need to walk unassisted for 15 minutes and have their condition confirmed by MRI or CT scan. All must speak English, weigh under 250 lbs, and have stable heart rates and blood pressure.
What is being tested?
The study tests different rehabilitation methods using robotics and neuromuscular modeling to improve walking function after stroke. It includes the use of a variable stiffness treadmill, belt accelerations alone, or combined with an exoskeleton to see which method best enhances gait.
What are the potential side effects?
Potential side effects may include muscle soreness due to exercise, fatigue from physical activity during testing sessions, joint discomfort from repetitive movements on the treadmill or exoskeleton use, and possible skin irritation where the exoskeleton contacts the body.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and during intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Contralateral plantarflexor muscle activation during exposure to belt accelerations
Contralateral plantarflexor muscle activation during exposure to combined exposure to belt accelerations and exoskeleton interaction
Contralateral plantarflexor muscle activation during exposure to lowered stiffness step perturbation
+6 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: All subjectsExperimental Treatment3 Interventions
All subjects (healthy and stroke survivors) participating in the study

Find a Location

Who is running the clinical trial?

University of DelawareLead Sponsor
162 Previous Clinical Trials
25,550 Total Patients Enrolled
12 Trials studying Stroke
4,401 Patients Enrolled for Stroke
~27 spots leftby Jun 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top